Cremer, Helmuth and Lozachmeur, Jean-Marie
 and Lozachmeur, Jean-Marie (2022)
Coinsurance vs. copayments: reimbursement rules for a monopolistic medical product with competitive health insurers.
  
    Journal of Health Economics, vol. 84 (n° 102642).
     pp. 1-11.
  
(2022)
Coinsurance vs. copayments: reimbursement rules for a monopolistic medical product with competitive health insurers.
  
    Journal of Health Economics, vol. 84 (n° 102642).
     pp. 1-11.
  	
  
  
  
This is the latest version of this item.
| Preview | Text Download (223kB) | Preview | 
Abstract
This paper studies a market for a medical product in which there is perfect competition among health insurers, while the good is sold by a monopolist. Individuals di§er in their severity of illness and there is ex post moral hazard. We consider two regimes: one in which insurers use coinsurance rates (ad valorem reimbursements) and one in which insurers use copayments (speciÖc reimbursements). We show that the induced equilibrium with copayments involves a lower producer price and a higher level of wel- fare for consumers. This results provides strong support for a reference price based reimbursement policy.
| Item Type: | Article | 
|---|---|
| Language: | English | 
| Date: | July 2022 | 
| Refereed: | Yes | 
| Uncontrolled Keywords: | Ex post moral hazard, Health insurance competition, Copayments, Imperfect competition | 
| JEL Classification: | I11 - Analysis of Health Care Markets I18 - Government Policy; Regulation; Public Health | 
| Subjects: | B- ECONOMIE ET FINANCE | 
| Divisions: | TSE-R (Toulouse) | 
| Site: | UT1 | 
| Date Deposited: | 13 Jan 2023 09:15 | 
| Last Modified: | 31 Jul 2023 01:00 | 
| OAI Identifier: | oai:tse-fr.eu:127009 | 
| URI: | https://publications.ut-capitole.fr/id/eprint/45489 | 
Available Versions of this Item
- 
Coinsurance vs. copayments : reimbursement rules for a monopolistic medical product with competitive health insurers. (deposited 15 Jun 2021 08:35)
- Coinsurance vs. copayments: reimbursement rules for a monopolistic medical product with competitive health insurers. (deposited 13 Jan 2023 09:15) [Currently Displayed]
 
 
  
                         
                        



 Tools
 Tools Tools
 Tools

